Vice President - Cardiorenal Strategy and Portfolio @ Eli Lilly and Company (March 2025 - April 2026)
Senior Vice President, Head of Biology and Translational Sciences @ (March 2023 - March 2025)
Vice President, Head of Biology @ (November 2017 - March 2023)
Senior Director, Head of Gastrointestinal, Metabolic, and Endocrine Research Therapeutic Area @ (March 2016 - October 2017)
Senior Director, Muscle Metabolism, Cardiovascular and Metabolic Disease Research Unit @ (April 2014 - March 2016)
Director, Diabetes Prevention and Remission Group, Cardiovascular and Metabolic Disease Research Unit @ (October 2013 - April 2014)
Lab head, Cardiovascular and Metabolic Disease Research Unit @ (May 2008 - September 2013)
Manager @ (January 1999 - January 2008)
Bryan Goodwin Education
University of Sydney
Doctor of Philosophy (Ph.D.) (Cell/Cellular and Molecular Biology)
1996-1999
Bryan Goodwin Skills
Assay Development
Biomarkers
Biotechnology
Clinical Development
Drug Development
Drug Discovery
In Vitro
In Vivo
Lifesciences
Oncology
Pharmaceutical Industry
Pharmacology
Public Speaking
Microsoft Office
PowerPoint
Molecular Biology
Leadership
Project Management
Microsoft Word
Bryan Goodwin Summary
Bryan Goodwin, based in Boston, MA, US, is currently a Chief Scientific Officer at NewCo at None. Bryan Goodwin brings experience from previous roles at Eli Lilly and Company, Morphic Therapeutic, Enanta Pharmaceuticals and Shire. Bryan Goodwin holds a 1996 - 1999 Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology @ University of Sydney. With a robust skill set that includes Assay Development, Biomarkers, Biotechnology, Clinical Development, Drug Development and more. Bryan Goodwin has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Bryan Goodwin?
Find contact details for 700 million professionals.